Table 1. Open in new tab Classification...

First-generation

Second-generation

Third-generation

Fourth-generation

J01DB01

Cefalexin^a

J01DC01

Cefoxitin

J01DD01

Cefotaxime

J01DE01

Cefepime

J01DB02

Cefaloridine^b

J01DC02

Cefuroxime^a

J01DD02

Ceftazidime

J01DE02

Cefpirome

J01DB03

Cefalotin

J01DC03

Cefamandole

J01DD03

Cefsulodin^b

J01DE03

Cefozopran^b

J01DB04

Cefazolin

J01DC04

Cefaclor^a

J01DD04

Ceftriaxone

J01DB05

Cefadroxil

J01DC05

Cefotetan^b

J01DD05

Cefmenoxime^b

J01DB06

Cefazedone^b

J01DC06

Cefonicide

J01DD06

Latamoxef^b

J01DB07

Cefatrizine

J01DC07

Cefotiam

J01DD07

Ceftizoxime

J01DB08

Cefapirin^b

J01DC08

Loracarbef

J01DD08

Cefixime^a

J01DB09

Cefradine

J01DC09

Cefmetazole^b

J01DD09

Cefodizime

J01DB10

Cefacetrile^b

J01DC10

Cefprozil^a

J01DD10

Cefetamet^b

J01DB11

Cefroxadine^b

J01DC11

Ceforanide

J01DD11

Cefpiramide^b

J01DB12

Ceftezole^b

J01DC12

Cefminox^c

J01DD12

Cefoperazone

J01DC13

Cefbuperazone^c

J01DD13

Cefpodoxime^a

J01DC14

Flomoxef^c

J01DD14

Ceftibuten

J01DD15

Cefdinir^b

J01DD16

Cefditoren

J01DD17

Cefcapene^b

J01DD51

Cefotaxime and BLI^c

J01DD52

Ceftazidime and BLI^c

J01DD54

Ceftriaxone

combinations

J01DD62

Cefoperazone and BLI

J01DD63

Ceftriaxone and BLI^c

Table 1.

Open in new tab

Classification of cephalosporins (J01DB, J01DC, J01DD and J01DE; ATC/DDD index 2019)

First-generation		Second-generation		Third-generation		Fourth-generation
J01DB01	Cefalexin^a	J01DC01	Cefoxitin	J01DD01	Cefotaxime	J01DE01	Cefepime
J01DB02	Cefaloridine^b	J01DC02	Cefuroxime^a	J01DD02	Ceftazidime	J01DE02	Cefpirome
J01DB03	Cefalotin	J01DC03	Cefamandole	J01DD03	Cefsulodin^b	J01DE03	Cefozopran^b
J01DB04	Cefazolin	J01DC04	Cefaclor^a	J01DD04	Ceftriaxone
J01DB05	Cefadroxil	J01DC05	Cefotetan^b	J01DD05	Cefmenoxime^b
J01DB06	Cefazedone^b	J01DC06	Cefonicide	J01DD06	Latamoxef^b
J01DB07	Cefatrizine	J01DC07	Cefotiam	J01DD07	Ceftizoxime
J01DB08	Cefapirin^b	J01DC08	Loracarbef	J01DD08	Cefixime^a
J01DB09	Cefradine	J01DC09	Cefmetazole^b	J01DD09	Cefodizime
J01DB10	Cefacetrile^b	J01DC10	Cefprozil^a	J01DD10	Cefetamet^b
J01DB11	Cefroxadine^b	J01DC11	Ceforanide	J01DD11	Cefpiramide^b
J01DB12	Ceftezole^b	J01DC12	Cefminox^c	J01DD12	Cefoperazone
		J01DC13	Cefbuperazone^c	J01DD13	Cefpodoxime^a
		J01DC14	Flomoxef^c	J01DD14	Ceftibuten
				J01DD15	Cefdinir^b
				J01DD16	Cefditoren
				J01DD17	Cefcapene^b
				J01DD51	Cefotaxime and BLI^c
				J01DD52	Ceftazidime and BLI^c
				J01DD54	Ceftriaxone combinations
				J01DD62	Cefoperazone and BLI
				J01DD63	Ceftriaxone and BLI^c

First-generation		Second-generation		Third-generation		Fourth-generation
J01DB01	Cefalexin^a	J01DC01	Cefoxitin	J01DD01	Cefotaxime	J01DE01	Cefepime
J01DB02	Cefaloridine^b	J01DC02	Cefuroxime^a	J01DD02	Ceftazidime	J01DE02	Cefpirome
J01DB03	Cefalotin	J01DC03	Cefamandole	J01DD03	Cefsulodin^b	J01DE03	Cefozopran^b
J01DB04	Cefazolin	J01DC04	Cefaclor^a	J01DD04	Ceftriaxone
J01DB05	Cefadroxil	J01DC05	Cefotetan^b	J01DD05	Cefmenoxime^b
J01DB06	Cefazedone^b	J01DC06	Cefonicide	J01DD06	Latamoxef^b
J01DB07	Cefatrizine	J01DC07	Cefotiam	J01DD07	Ceftizoxime
J01DB08	Cefapirin^b	J01DC08	Loracarbef	J01DD08	Cefixime^a
J01DB09	Cefradine	J01DC09	Cefmetazole^b	J01DD09	Cefodizime
J01DB10	Cefacetrile^b	J01DC10	Cefprozil^a	J01DD10	Cefetamet^b
J01DB11	Cefroxadine^b	J01DC11	Ceforanide	J01DD11	Cefpiramide^b
J01DB12	Ceftezole^b	J01DC12	Cefminox^c	J01DD12	Cefoperazone
		J01DC13	Cefbuperazone^c	J01DD13	Cefpodoxime^a
		J01DC14	Flomoxef^c	J01DD14	Ceftibuten
				J01DD15	Cefdinir^b
				J01DD16	Cefditoren
				J01DD17	Cefcapene^b
				J01DD51	Cefotaxime and BLI^c
				J01DD52	Ceftazidime and BLI^c
				J01DD54	Ceftriaxone combinations
				J01DD62	Cefoperazone and BLI
				J01DD63	Ceftriaxone and BLI^c

BLI, β-lactamase inhibitor; Bold type indicates that consumption was part of the top 90% of the community consumption of cephalosporins (J01DB, J01DC, J01DD and J01DE) in 28 EU/EEA countries in 2017; Italic type indicates that no consumption of this cephalosporin was reported in 28 EU/EEA countries in 2017.

Consumption was part of the top 90% of the community consumption of cephalosporins (J01DB, J01DC, J01DD and J01DE) in 30 EU/EEA countries in 2009.

No consumption of this cephalosporin was reported in 30 EU/EEA countries in 2009.

This cephalosporin was not included in the ATC/DDD index in 2009 and was therefore not reported in 2009.

This Feature Is Available To Subscribers Only